Tag: hematologic malignancies

Home / hematologic malignancies

Categories

Bridging The Gaps In CAR T Cell therapy

 CAR T Cell therapyChimeric Antigen Receptor (CAR) T-cell therapy is a revolutionary therapeutic strategy in hematologic malignancy treatment, recording high remission rates in therapy-refractory cas...
hematologic-malignancies

Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies: Experience from China

 CAR T Cell therapyChimeric Antigen Receptor (CAR) T-cell therapy has changed the course of treatment for numerous hematologic malignancies like leukemia, lymphoma, and multiple myeloma. China is at ...
hematologic-malignancies

Scan the code